OPL-CXCL12-LPM

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameOPL-CXCL12-LPM
Drug Alias NameCXCR4 targeting agent (Osprey)leukocyte population modulator (Osprey)LPM (Osprey)OPL-CXCL12-LPM
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Toxin
Mechanisms of ActionC-X-C motif chemokine receptor 4 modulators
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsArthritisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOsprey Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOsprey Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsArthritisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A